{
    "paper_id": "PMC7182525",
    "metadata": {
        "title": "Probiotics and COVID-19: one size does not fit all",
        "authors": [
            {
                "first": "Joyce",
                "middle": [
                    "W",
                    "Y"
                ],
                "last": "Mak",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Francis",
                "middle": [
                    "K",
                    "L"
                ],
                "last": "Chan",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Siew",
                "middle": [
                    "C"
                ],
                "last": "Ng",
                "suffix": "",
                "email": "siewchienng@cuhk.edu.hk",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "As of April 20, 2020, coronavirus disease 2019 (COVID-19) has affected more than 2 million people globally. In February, 2020, China's National Health Commission and National Administration of Traditional Chinese Medicine suggested the use of probiotics in patients with severe COVID-19.1 We reviewed the evidence for the role of probiotics in COVID-19-related illnesses (appendix).",
            "cite_spans": [
                {
                    "start": 287,
                    "end": 288,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "In China, 58\u201371% of patients with COVID-19 were given antibiotics, and diarrhoea occurred in 2\u201336% of patients.2, 3, 4 When antibiotics are used, reinforcement of colonic flora using probiotics has been proposed to reduce susceptibility to subsequent infections. Although a 2012 meta-analysis5 showed that probiotics have modest efficacy in reducing antibiotic-associated diarrhoea, the largest randomised, placebo-controlled trial (involving 2941 participants) showed that a 21-day treatment of combined Lactobacilli and Bifidobacteria did not reduce antibiotic-associated diarrhoea.6 Even if probiotics are useful, they are unlikely to have a direct effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; most patients with COVID-19 present with respiratory symptoms. However, gut\u2013lung crosstalk has been proposed in the pathogenesis of certain respiratory conditions. Two meta-analyses reported modest efficacy of probiotics in reducing the incidence and duration of respiratory tract infections of viral origin.7, 8 During the COVID-19 pandemic, 2\u201347% of infected patients required invasive mechanical ventilation.3, 4 Two randomised controlled trials showed that critically ill patients on mechanical ventilation who were given probiotics (Lactobacillus rhamnosus GG, live Bacillus subtilis, and Enterococcus faecalis) developed substantially less ventilator-associated pneumonia compared with placebo.9, 10 However, the efficacy of probiotics in reduction of intensive care unit mortality and inpatient mortality is uncertain.",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 112,
                    "mention": "2",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 114,
                    "end": 115,
                    "mention": "3",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 117,
                    "end": 118,
                    "mention": "4",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 292,
                    "end": 293,
                    "mention": "5",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 584,
                    "end": 585,
                    "mention": "6",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 1042,
                    "end": 1043,
                    "mention": "7",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1045,
                    "end": 1046,
                    "mention": "8",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1145,
                    "end": 1146,
                    "mention": "3",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 1148,
                    "end": 1149,
                    "mention": "4",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1434,
                    "end": 1435,
                    "mention": "9",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1437,
                    "end": 1439,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Scarce data are available on the effect of COVID-19 on intestinal microbiota. A small case series from China revealed that some patients with COVID-19 showed microbial dysbiosis with decreased Lactobacillus and Bifidobacterium.11 However, animal studies (as yet, not peer-reviewed) showed that Lactobacillus acidophilus and Bacillus clausii did not reduce coronavirus receptor expression in the murine small intestine compared with control and post-Salmonella infection models.12 Not all probiotics are likely to be the same. Lactobacilli and Bifidobacteria are only two types of non-pathogenic bacteria and we must consider whether they can really tip the balance of a diverse gut ecosystem in combating COVID-19. To date, the rationale for using probiotics in COVID-19 is derived from indirect evidence. Blind use of conventional probiotics for COVID-19 is not recommended until we have further understanding of the pathogenesis of SARS-CoV-2 and its effect on gut microbiota. It is likely that a novel and more targeted approach to modulation of gut microbiota as one of the therapeutic approaches of COVID-19 and its comorbidities will be necessary.",
            "cite_spans": [
                {
                    "start": 227,
                    "end": 229,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 477,
                    "end": 479,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Diagnostic and therapeutic guidance for 2019 novel coronavirus disease (version 5)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "CT",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "FS",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Intensive Care Med",
            "volume": "42",
            "issn": "",
            "pages": "1018-1028",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Management of corona virus disease-19 (COVID-19): the Zhejiang experience",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Zhejiang Da Xue Xue Bao Yi Xue Ban",
            "volume": "49",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "The small intestine, an underestimated site of SARS-CoV-2 infection: from red queen effect to probiotics",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Qi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Preprints",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.20944/preprints202003.0161.v1"
                ]
            }
        },
        "BIBREF4": {
            "title": "COVID-19 and the digestive system",
            "authors": [
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "RNS",
                    "middle": [],
                    "last": "Lui",
                    "suffix": ""
                },
                {
                    "first": "JJY",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Gastroenterol Hepatol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1111/jgh.15047"
                ]
            }
        },
        "BIBREF5": {
            "title": "Clinical characteristics of coronavirus disease 2019 in China",
            "authors": [
                {
                    "first": "WJ",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "ZY",
                    "middle": [],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hempel",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Newberry",
                    "suffix": ""
                },
                {
                    "first": "AR",
                    "middle": [],
                    "last": "Maher",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "JAMA",
            "volume": "307",
            "issn": "",
            "pages": "1959-1969",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Lactobacilli and Bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial",
            "authors": [
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wareham",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Lancet",
            "volume": "382",
            "issn": "",
            "pages": "1249-1257",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "King",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Glanville",
                    "suffix": ""
                },
                {
                    "first": "ME",
                    "middle": [],
                    "last": "Sanders",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fitzgerald",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Varley",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Br J Nutr",
            "volume": "112",
            "issn": "",
            "pages": "41-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Probiotics for preventing acute upper respiratory tract infections",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Hao",
                    "suffix": ""
                },
                {
                    "first": "BR",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Cochrane Database Syst Rev",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial",
            "authors": [
                {
                    "first": "LE",
                    "middle": [],
                    "last": "Morrow",
                    "suffix": ""
                },
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Kollef",
                    "suffix": ""
                },
                {
                    "first": "TB",
                    "middle": [],
                    "last": "Casale",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am J Respir Crit Care Med",
            "volume": "182",
            "issn": "",
            "pages": "1058-1064",
            "other_ids": {
                "DOI": []
            }
        }
    }
}